Rowan Chapman, PhD
Head of Johnson & Johnson Innovation, California Innovation Center
Rowan Chapman is head of J&J Innovation, CA. She leads the team responsible for identifying, investing and partnering with the entrepreneurial ecosystem across the J&J Pharmaceutical, Medical Device and Consumer sectors.
Prior to J&J Rowan served as head of healthcare investing at GE Ventures. There she led the team responsible for GE Ventures’ healthcare investing strategy and portfolio as well as managing partnerships and thought leadership with a particular focus on digital health, data analytics and precision medicine.
Before GE, she spent 11 years as a Partner at Mohr Davidow Ventures, where she drove development of the life science investment strategy and practice area. Rowan invested in and held board director and observer roles across a spectrum of healthcare and life science companies, including Adamas (IPO: ADMS), Balance Therapeutics, HealthTap, RainDance, Pacific Biosciences (IPO: PACB), ParAllele (acquired: AFFX), Sequenta (acquired: Adaptive) and Verinata (acquired: ILMN).